2025
Marie Ali et al.
An acyclic nucleoside phosphonate effectively blocks the egress of the malaria parasite by inhibiting the synthesis of cyclic GMP
Science Advances 2025, vol. 11, issue 47
doi: 10.1126/sciadv.ady2859
Isabella Hofer et al.
An Extracellular Matrix–Producing Subset of Cancer-Associated Fibroblasts Drives Chemoresistance in Breast Cancer via SRC Activation and G0S2 Upregulation
Cancer Research 2025, vol. 86, issue 4
doi: 10.1158/0008-5472.can-25-0966
Léa Baudre et al.
Characterization of Drug-Tolerant Persister Cells in Triple-Negative Breast Cancer Identifies a Shared Persistence Program across Treatments and Patients
Cancer Research 2025, vol. 86, issue 3
doi: 10.1158/0008-5472.can-25-0995
F. Nowak et al.
2283MO PFMG2025: Integrating genomic medicine into the national healthcare system in France
Annals of Oncology 2025, vol. 36
doi: 10.1016/j.annonc.2025.08.2899
Louna Fruchard et al.
Beyond RNA modification: a novel role for tRNA modifying enzyme in oxidative stress response and metabolism
Nucleic Acids Research 2025, vol. 53, issue 22
doi: 10.1093/nar/gkaf1276
Alexandre Devaux et al.
Identification of microprotein-coding intronic polyadenylation isoforms and function in genotoxic anticancer drug response
Genome Biology 2025, vol. 26, issue 1
doi: 10.1186/s13059-025-03829-7
Skyler Friedline et al.
Activity-targeted metaproteomics uncovers rare syntrophic bacteria central to anaerobic community metabolism
Nature Microbiology 2025, vol. 10, issue 11
doi: 10.1038/s41564-025-02146-w
Caridad Miró-Pina et al.
A histone methyltransferase-independent function of PRC2 controls small RNA dynamics during programmed DNA elimination in Paramecium
Nucleic Acids Research 2025, vol. 53, issue 19
doi: 10.1093/nar/gkaf1048
Salima El Chehadeh et al.
Genome sequencing for the diagnosis of intellectual disability as a paradigm for rare diseases in the French healthcare setting: the prospective DEFIDIAG study
Genome Medicine 2025, vol. 17, issue 1
doi: 10.1186/s13073-025-01527-4
Fatima Alhourani et al.
Targeting SUV4-20H Epigenetic Enzymes Enhances Topoisomerase II Poisoning in Prostate Cancer
Cancer Research 2025, vol. 86, issue 1
doi: 10.1158/0008-5472.can-24-3974